How will innovation continue to bridge commercialization service industry gaps to improve access, affordability and adherence for patients? In this session, Scott Snyder and industry experts will discuss the significance of the direct-to-patient model and the key factors for successful implementation. The conversation will outline how brands need to integrate digital solutions—telehealth, data analytics, generative AI, machine learning and market access resources—to provide a personalized approach to patient care. 

Speakers

Scott Snyder, Chief Digital Officer EVERSANA [Moderator]
Davide Bottalico, Strategic Client Partner, International Markets Pfizer
Brandon Drew, Senior Vice President & Global Head, Developed Brands UCB
Malin Johansson, Vice President, Digital Health Partnerships and Commercialisation Novo Nordisk